The endogenous thrombin potential and the risk of venous thromboembolism

Armando Tripodi, Ida Martinelli, Veena Chantarangkul, Tullia Battaglioli, Marigrazia Clerici, Pier Mannuccio Mannucci

Research output: Contribution to journalArticle

Abstract

Background: The risk of venous thromboembolism (VTE) is increased by an excess of procoagulant or by a defect of anticoagulant proteins, with circumstantial risk factors playing a significant contribution. These conditions are directly linked to or are compatible with increased thrombin generation. Assuming that the more thrombin is generated the higher is the risk of VTE, an overall coagulation test monitoring ex vivo thrombin generation and reflecting the interaction of pro- and anticoagulant proteins would be useful to determine the risk of VTE. Patients and methods: This hypothesis was tested by measuring the endogenous thrombin potential (ETP) without or with thrombomodulin (TM) in plasmas from 403 individuals stratified according to their relative risk of VTE (no, low, intermediate, or high risk) according to whether or not they had congenital and/or circumstantial risk factors. Odds ratio (OR) and 95% confidence interval (CI), taken as a measure of the relative risk of having high levels of ETP, were calculated for the different categories relatively to the no-risk category. Results: When the ETP was measured with TM, ORs (95% CI) were 2.10 (1.23-3.60); 4.03 (2.18-7.45) and 4.96 (2.40-10.23) for the low-, intermediate and high-risk category. When ETP was measured without TM there was no gradient of OR values as function of the risk category. Conclusions: ETP measured with TM may help to distinguish individuals with different risk of VTE, however, the practical utility of measuring ETP in clinical practice remains to be evaluated in prospective studies.

Original languageEnglish
Pages (from-to)353-359
Number of pages7
JournalThrombosis Research
Volume121
Issue number3
DOIs
Publication statusPublished - 2007

Fingerprint

Venous Thromboembolism
Thrombin
Thrombomodulin
Anticoagulants
Odds Ratio
Confidence Intervals
Proteins
Prospective Studies

Keywords

  • Laboratory testing
  • Screening
  • Thrombin generation
  • Thrombophilia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

The endogenous thrombin potential and the risk of venous thromboembolism. / Tripodi, Armando; Martinelli, Ida; Chantarangkul, Veena; Battaglioli, Tullia; Clerici, Marigrazia; Mannucci, Pier Mannuccio.

In: Thrombosis Research, Vol. 121, No. 3, 2007, p. 353-359.

Research output: Contribution to journalArticle

@article{6b129bf5fe3b4b868a4d4c40df3e747e,
title = "The endogenous thrombin potential and the risk of venous thromboembolism",
abstract = "Background: The risk of venous thromboembolism (VTE) is increased by an excess of procoagulant or by a defect of anticoagulant proteins, with circumstantial risk factors playing a significant contribution. These conditions are directly linked to or are compatible with increased thrombin generation. Assuming that the more thrombin is generated the higher is the risk of VTE, an overall coagulation test monitoring ex vivo thrombin generation and reflecting the interaction of pro- and anticoagulant proteins would be useful to determine the risk of VTE. Patients and methods: This hypothesis was tested by measuring the endogenous thrombin potential (ETP) without or with thrombomodulin (TM) in plasmas from 403 individuals stratified according to their relative risk of VTE (no, low, intermediate, or high risk) according to whether or not they had congenital and/or circumstantial risk factors. Odds ratio (OR) and 95{\%} confidence interval (CI), taken as a measure of the relative risk of having high levels of ETP, were calculated for the different categories relatively to the no-risk category. Results: When the ETP was measured with TM, ORs (95{\%} CI) were 2.10 (1.23-3.60); 4.03 (2.18-7.45) and 4.96 (2.40-10.23) for the low-, intermediate and high-risk category. When ETP was measured without TM there was no gradient of OR values as function of the risk category. Conclusions: ETP measured with TM may help to distinguish individuals with different risk of VTE, however, the practical utility of measuring ETP in clinical practice remains to be evaluated in prospective studies.",
keywords = "Laboratory testing, Screening, Thrombin generation, Thrombophilia",
author = "Armando Tripodi and Ida Martinelli and Veena Chantarangkul and Tullia Battaglioli and Marigrazia Clerici and Mannucci, {Pier Mannuccio}",
year = "2007",
doi = "10.1016/j.thromres.2007.04.012",
language = "English",
volume = "121",
pages = "353--359",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - The endogenous thrombin potential and the risk of venous thromboembolism

AU - Tripodi, Armando

AU - Martinelli, Ida

AU - Chantarangkul, Veena

AU - Battaglioli, Tullia

AU - Clerici, Marigrazia

AU - Mannucci, Pier Mannuccio

PY - 2007

Y1 - 2007

N2 - Background: The risk of venous thromboembolism (VTE) is increased by an excess of procoagulant or by a defect of anticoagulant proteins, with circumstantial risk factors playing a significant contribution. These conditions are directly linked to or are compatible with increased thrombin generation. Assuming that the more thrombin is generated the higher is the risk of VTE, an overall coagulation test monitoring ex vivo thrombin generation and reflecting the interaction of pro- and anticoagulant proteins would be useful to determine the risk of VTE. Patients and methods: This hypothesis was tested by measuring the endogenous thrombin potential (ETP) without or with thrombomodulin (TM) in plasmas from 403 individuals stratified according to their relative risk of VTE (no, low, intermediate, or high risk) according to whether or not they had congenital and/or circumstantial risk factors. Odds ratio (OR) and 95% confidence interval (CI), taken as a measure of the relative risk of having high levels of ETP, were calculated for the different categories relatively to the no-risk category. Results: When the ETP was measured with TM, ORs (95% CI) were 2.10 (1.23-3.60); 4.03 (2.18-7.45) and 4.96 (2.40-10.23) for the low-, intermediate and high-risk category. When ETP was measured without TM there was no gradient of OR values as function of the risk category. Conclusions: ETP measured with TM may help to distinguish individuals with different risk of VTE, however, the practical utility of measuring ETP in clinical practice remains to be evaluated in prospective studies.

AB - Background: The risk of venous thromboembolism (VTE) is increased by an excess of procoagulant or by a defect of anticoagulant proteins, with circumstantial risk factors playing a significant contribution. These conditions are directly linked to or are compatible with increased thrombin generation. Assuming that the more thrombin is generated the higher is the risk of VTE, an overall coagulation test monitoring ex vivo thrombin generation and reflecting the interaction of pro- and anticoagulant proteins would be useful to determine the risk of VTE. Patients and methods: This hypothesis was tested by measuring the endogenous thrombin potential (ETP) without or with thrombomodulin (TM) in plasmas from 403 individuals stratified according to their relative risk of VTE (no, low, intermediate, or high risk) according to whether or not they had congenital and/or circumstantial risk factors. Odds ratio (OR) and 95% confidence interval (CI), taken as a measure of the relative risk of having high levels of ETP, were calculated for the different categories relatively to the no-risk category. Results: When the ETP was measured with TM, ORs (95% CI) were 2.10 (1.23-3.60); 4.03 (2.18-7.45) and 4.96 (2.40-10.23) for the low-, intermediate and high-risk category. When ETP was measured without TM there was no gradient of OR values as function of the risk category. Conclusions: ETP measured with TM may help to distinguish individuals with different risk of VTE, however, the practical utility of measuring ETP in clinical practice remains to be evaluated in prospective studies.

KW - Laboratory testing

KW - Screening

KW - Thrombin generation

KW - Thrombophilia

UR - http://www.scopus.com/inward/record.url?scp=37648999269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37648999269&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2007.04.012

DO - 10.1016/j.thromres.2007.04.012

M3 - Article

C2 - 17560633

AN - SCOPUS:37648999269

VL - 121

SP - 353

EP - 359

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 3

ER -